ad

Nifty Pharma Prediction for Tomorrow, 5 November 2026 (Including F&O)

Nifty Pharma closed at 27,333.45, up 0.42%. Nifty 50 rose 0.63%. India VIX fell 3.37% to 15.19. Next session is tomorrow, Thursday 5 November.


4 Nov 2026 • 4:37 pm

Nifty Pharma Prediction for Tomorrow, 5 November 2026 (Including F&O)

Quick Answer

The nifty pharma prediction for tomorrow is mildly constructive for tomorrow, 5 November 2026. Nifty Pharma rose 0.42 percent to 27,333.45 on Wednesday, a second straight gain, while the Nifty 50 rose 0.63 percent. The index climbed about 225 points from its low of 27,108.75 and finished near its high of 27,386.45.

This nifty pharma prediction for tomorrow follows a Wednesday, 4 November 2026 session in which the Nifty Pharma index rose 0.42 percent to 27,333.45, a second straight gain of the same size, and closed within about 53 points of its high.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are tracking sector-specific triggers and F&O positioning ahead of the session tomorrow, which falls on Thursday, 5 November 2026.

Click Here – Get Free Investment Predictions

What Wednesday Told Us

  • Nifty Pharma closed at 27,333.45, up 0.42 percent on 4 November 2026.
  • The broader Nifty 50 rose 0.63 percent.
  • India VIX fell 3.37 percent to 15.19.

Nifty Pharma Prediction for Tomorrow: Key Levels

Nifty Pharma traded between 27,108.75 and 27,386.45 on Wednesday, against a previous close of 27,218.50, and settled at 27,333.45. On the downside, 27,218.50 and 27,108.75 are the first reference levels to watch if the day's move is tested. On the upside, 27,386.45 marks the nearest resistance. Univest's analysts treat these as reference points drawn from Wednesday's trading range, not as targets.

Trend Support Resistance
Positive 27,218.50, 27,108.75 27,386.45

The table uses Wednesday's high, low and previous close for Nifty Pharma.

Key Drivers for Tomorrow

  • Nifty Pharma rose 0.42 percent to 27,333.45, with a high of 27,386.45 and a low of 27,108.75.
  • The index climbed about 225 points from its low and closed near the day's high.
  • The index lagged the Nifty 50's 0.63 percent gain, so pharma trailed the market slightly.

Ankit Jaiswal and Kunal Singla suggest revisiting this nifty pharma prediction for tomorrow after the first thirty minutes of Thursday's trade.

Anyone following this nifty pharma prediction for tomorrow should keep the next session's opening range in view before reading too much into early moves.

Nothing in this nifty pharma prediction for tomorrow is a promise of returns, and every level quoted can fail.

Stocks and Triggers to Watch in the Nifty Pharma Space

Nifty Pharma is a defensive-growth gauge. A second steady gain with a close near the high shows buyers in control, though lagging the market is a mild caution. US generic pricing and export updates are the usual triggers.

In the F&O segment, the nearest weekly Nifty options expiry in the data is 9 November 2026. Among the strikes Univest checked for that series, call open interest was highest at the 24,000 strike and put open interest was highest at the 23,500 strike, with a put-call ratio of approximately 1.08. India VIX fell 3.37 percent to 15.19, and Univest's analysts treat these strikes as reference points, not predictions.

Univest's analysts suggest treating this nifty pharma prediction for tomorrow as a preparation note for Thursday, 5 November 2026, rather than a signal that changes overnight.

These are educational views, not buy calls, and each should be checked against your own risk plan before acting.

How Wednesday's Broader Session Unfolded

The Nifty 50 closed at 23,960.60, up 0.63 percent, with a high of 23,960.60 and a low of 23,696.15, so it finished at the best level of the day after opening about 69 points below Tuesday's close. The Sensex closed at 77,301.40, up 0.50 percent, and the Bank Nifty closed at 55,913.60, up 0.67 percent. India VIX, the market's fear gauge, fell 3.37 percent to 15.19, after ranging between 15.13 and 16.15 during the session. This was the fourth straight daily gain for both the Nifty 50 and the Sensex, and the Nifty 50 is now about 3.5 percent above its close of 23,146.15 on 16 October. The Nifty Midcap 50 rose 1.42 percent, the Nifty Next 50 rose 1.68 percent and the Nifty Smallcap 250 rose 1.97 percent, so the rise was broader than the headline index. Nifty Metal rose 2.80 percent and Nifty FMCG rose 1.50 percent, while Nifty IT fell 1.50 percent. The trigger for the broad rise was not independently confirmed.

This nifty pharma prediction for tomorrow will be most useful when read alongside the support and resistance table above.

Analyst View for Tomorrow

Kunal Singla suggests that the index can hold above 27,218.50, the previous close, with a fresh high above 27,386.45 needed to extend the move.

Ankit Jaiswal flags that a steady second gain is firm, but the index needs to hold above 27,218.50.

A fair reading of this nifty pharma prediction for tomorrow is that Wednesday's data sets the context, while Thursday's first hour decides how much of it carries forward.

Why This Is Written for Tomorrow

This nifty pharma prediction for tomorrow is written after the close on Wednesday, 4 November 2026, using Wednesday's closing data, for the next trading session tomorrow, Thursday, 5 November 2026. Treat it as a briefing to prepare for that session, not a live call that updates through the evening.

Track the Nifty Pharma Space on Univest Screeners

Readers comparing views should note that this nifty pharma prediction for tomorrow draws only on Wednesday's closing numbers and the factors listed here.

Risks to This Prediction

  • A stronger rupee can hurt export earnings.
  • US regulatory news can move pharma stocks sharply.
  • Lagging a rising market suggests money is flowing elsewhere.

As with any nifty pharma prediction for tomorrow, the opening minutes of Thursday's trade will confirm or challenge the levels discussed here.

The nifty pharma prediction for tomorrow also depends on India VIX, so a fresh rise in volatility would weaken the case made here.

Download the Univest iOS App or Univest Android App to get daily market recommendations and insightful research pieces.

Conclusion

The nifty pharma prediction for tomorrow leans mildly constructive into 5 November 2026, with broader Nifty 50 direction and India VIX as the key variables to track. Ankit Jaiswal and Kunal Singla will revisit this view once Thursday's opening trade confirms direction.

For traders, this nifty pharma prediction for tomorrow is a framework for planning risk, with position size and stop levels left to the individual.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow?

Ans. It is mildly constructive for 5 November 2026, after Nifty Pharma closed at 27,333.45 on Wednesday, up 0.42 percent.

Why is this a prediction for tomorrow, 5 November 2026?

Ans. Because it is written after the close on Wednesday, 4 November 2026, for the next regular trading session on Thursday, 5 November 2026.

Why did Nifty Pharma rise on Wednesday?

Ans. Nifty Pharma rose 0.42 percent while the Nifty 50 rose 0.63 percent. The specific trigger was not independently confirmed.

What are the key Nifty Pharma levels for tomorrow?

Ans. The previous close of 27,218.50 and Wednesday's low of 27,108.75 are support below the price, while Wednesday's high of 27,386.45 is the nearest resistance.

Is this a buy or sell call?

Ans. No. This is an educational outlook from Univest's research team, not a buy or sell call. Traders should check any view against their own risk plan before acting.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down